Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Mark A. MoraisCOO & President of Clinical Services | -4,87k | 75,37k | Derivative Exercise and Sale | 15,49 | 80,66k | - |
| 2026-06-01 | Mr. Mark A. MoraisCOO & President of Clinical Services | 6,14k | 0,00 | Derivative Exercise and Retained Stock | - | 80,66k | 8,24% |
| 2026-06-01 | Ms. Jill McConnellCFO | -4,87k | 75,37k | Derivative Exercise and Sale | 15,49 | 78,42k | - |
| 2026-06-01 | Ms. Jill McConnellCFO | 6,14k | 0,00 | Derivative Exercise and Retained Stock | - | 78,42k | 8,50% |
| 2026-05-18 | Mr. Robert ParksCAO | -2,00k | 26,88k | Vendita | 13,44 | 20,39k | -8,93% |
| 2026-05-14 | Mr. Peter M. NeupertChairman of the Board & Lead Independent Director | 148,54k | 0,00 | Derivative Exercise and Retained Stock | - | 246,67k | 151,36% |
| 2026-03-20 | Ms. Erin L. RussellIndependent Director | 23,95k | 0,00 | Derivative Exercise and Retained Stock | - | 33,80k | 243,01% |
| 2026-03-13 | Mr. Mark A. MoraisCOO & President of Clinical Services | 2,48k | 0,00 | Derivative Exercise and Retained Stock | - | 74,52k | 3,44% |
| 2026-03-13 | Mr. Mark A. MoraisCOO & President of Clinical Services | -1,80k | 16,63k | Derivative Exercise and Sale | 9,22 | 74,52k | - |
| 2026-03-13 | Ms. Jill McConnellCFO | 2,48k | 0,00 | Derivative Exercise and Retained Stock | - | 72,28k | 3,55% |
| 2026-03-13 | Ms. Jill McConnellCFO | -1,80k | 16,63k | Derivative Exercise and Sale | 9,22 | 72,28k | - |
| 2026-03-09 | Mr. Robert ParksCAO | 3,34k | 0,00 | Derivative Exercise and Retained Stock | - | 22,39k | 17,55% |
| 2026-03-09 | Mr. Robert ParksCAO | -1,93k | 17,48k | Derivative Exercise and Sale | 8,93 - 9,21 | 22,39k | - |
| 2026-03-09 | Mr. Mark A. MoraisCOO & President of Clinical Services | 9,37k | 0,00 | Derivative Exercise and Retained Stock | - | 72,04k | 14,94% |
| 2026-03-09 | Mr. Mark A. MoraisCOO & President of Clinical Services | -4,60k | 41,71k | Derivative Exercise and Sale | 8,93 - 9,21 | 72,04k | - |
| 2026-03-09 | Ms. Jill McConnellCFO | 10,22k | 0,00 | Derivative Exercise and Retained Stock | - | 69,80k | 17,16% |
| 2026-03-09 | Ms. Jill McConnellCFO | -5,06k | 45,90k | Derivative Exercise and Sale | 8,93 - 9,21 | 69,80k | - |
| 2026-02-09 | Mr. Mark A. MoraisCOO & President of Clinical Services | 1,08k | 0,00 | Derivative Exercise and Retained Stock | - | 62,68k | 1,75% |
| 2026-02-09 | Mr. Mark A. MoraisCOO & President of Clinical Services | -1,18k | 16,36k | Derivative Exercise and Sale | 13,65 - 14,11 | 62,68k | - |
| 2026-02-09 | Ms. Jill McConnellCFO | 804,00 | 0,00 | Derivative Exercise and Retained Stock | - | 59,57k | 1,37% |
| 2026-02-09 | Ms. Jill McConnellCFO | -881,00 | 12,23k | Derivative Exercise and Sale | 13,65 - 14,11 | 59,57k | - |
| 2025-09-15 | Mr. Robert ParksCAO | 17,60k | 0,00 | Derivative Exercise and Retained Stock | - | 19,05k | 1.213,52% |
| 2025-09-15 | Mr. Robert ParksCAO | -7,34k | 73,01k | Derivative Exercise and Sale | 9,95 | 19,05k | - |
| 2025-09-08 | Mr. Robert ParksCAO | 1,45k | 0,00 | Derivative Exercise and Retained Stock | - | 1,45k | - |
| 2025-09-08 | Mr. Robert ParksCAO | -592,00 | 6,06k | Derivative Exercise and Sale | 10,23 | 1,45k | - |
| 2025-09-08 | Mr. James Stillman HansonInsider | 4,11k | 0,00 | Derivative Exercise and Retained Stock | - | 19,09k | 27,44% |
| 2025-09-08 | Mr. James Stillman HansonInsider | -1,68k | 17,16k | Derivative Exercise and Sale | 10,23 | 19,09k | - |
| 2025-09-08 | Mr. Mark A. MoraisCOO & President of Clinical Services | 4,00k | 0,00 | Derivative Exercise and Retained Stock | - | 61,60k | 6,95% |
| 2025-09-08 | Mr. Mark A. MoraisCOO & President of Clinical Services | -3,16k | 32,28k | Derivative Exercise and Sale | 10,23 | 61,60k | - |
| 2025-09-08 | Ms. Jill McConnellCFO | 4,00k | 0,00 | Derivative Exercise and Retained Stock | - | 58,77k | 7,30% |
| 2025-09-08 | Ms. Jill McConnellCFO | -3,16k | 32,29k | Derivative Exercise and Sale | 10,23 | 58,77k | - |
| 2025-09-02 | Ms. Erin L. RussellIndependent Director | 9,85k | 100,02k | Acquisto | 10,15 | 9,85k | - |
| 2025-08-18 | Mr. Mark A. MoraisCOO & President of Clinical Services | 6,43k | 0,00 | Derivative Exercise and Retained Stock | - | 57,60k | 12,56% |
| 2025-08-18 | Mr. Mark A. MoraisCOO & President of Clinical Services | -4,89k | 39,14k | Derivative Exercise and Sale | 8,01 | 57,60k | - |
| 2025-08-18 | Ms. Jill McConnellCFO | 6,43k | 0,00 | Derivative Exercise and Retained Stock | - | 54,77k | 13,29% |
| 2025-08-18 | Ms. Jill McConnellCFO | -4,89k | 39,14k | Derivative Exercise and Sale | 8,01 | 54,77k | - |
| 2025-08-08 | Mr. Peter M. NeupertChairman of the Board & Lead Independent Director | 62,50k | 407,15k | Acquisto | 6,26 - 6,79 | 98,13k | 175,40% |
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
